Cardiac effects of myoregulin in ischemia-reperfusion

Sarah Appleby,Hamish M. Aitken-Buck,Mark S. Holdaway,Mathew S. Byers,Chris M. Frampton,Louise N. Paton,A. Mark Richards,Regis R. Lamberts,Christopher J. Pemberton
DOI: https://doi.org/10.1016/j.peptides.2024.171156
IF: 3.867
2024-01-21
Peptides
Abstract:Myoregulin is a recently discovered micropeptide that controls calcium levels by inhibiting the intracellular calcium pump sarco-endoplasmic reticulum Ca 2+ -ATPase (SERCA). Keeping calcium levels balanced in the heart is essential for normal heart functioning, thus myoregulin has the potential to be a crucial regulator of cardiac muscle performance by reducing the rate of intracellular Ca 2+ uptake. We provide the first report of myoregulin mRNA expression in human heart tissue, absence of expression in human plasma, and the effects of myoregulin on cardiac hemodynamics in an ex vivo Langendorff isolated rat heart model of ischemia/reperfusion. In this preliminary study, myoregulin provided a cardio-protective effect, as assessed by preservation of left ventricular contractility and relaxation, during ischemia/reperfusion. This study provides the foundation for future research in this area.
pharmacology & pharmacy,biochemistry & molecular biology,endocrinology & metabolism
What problem does this paper attempt to address?